SCHEMBL6360871

SCHEMBL6360871

CN1CCC(COc2ccc3c(c2)C=CC(=C2C(=O)Nc4ccccc42)N3)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.41
MAOB P27338 2/20 0.41
CASP3 P42574 2/20 0.39
CASP7 P55210 2/20 0.39
CASP1 P29466 1/20 0.39
CASP2 P42575 1/20 0.39
CASP4 P49662 1/20 0.39
CASP9 P55211 1/20 0.39
CASP6 P55212 1/20 0.39
CASP8 Q14790 1/20 0.39
PRMT5 O14744 3/20 0.38
WDR77 Q9BQA1 3/20 0.38
CXCR1 P25024 1/20 0.38
TLK2 Q86UE8 1/20 0.38
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
BRD4 O60885 1/20 0.36
CREBBP Q92793 1/20 0.36
CHEK1 O14757 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6360867 1.00 MAOA (0.41) MAOAMAOBCASP3CASP7CASP1
Hydrochloric Acid SCHEMBL6353019 0.87 SLC6A2 (0.46) MAOAMAOBBRD4CREBBP
Hydrochloric Acid SCHEMBL6353016 0.87 SLC6A2 (0.46) MAOAMAOBBRD4CREBBP
SCHEMBL6355225 0.81 ALDH1A1 (0.41) MAOAMAOBCASP3CASP7CASP1
SCHEMBL6355223 0.81 ALDH1A1 (0.41) MAOAMAOBCASP3CASP7CASP1
SCHEMBL1250665 0.77 FLT3 (0.50) ALDH1A1CHEK1
SCHEMBL1250660 0.77 FLT3 (0.50) ALDH1A1CHEK1
SCHEMBL6354675 0.77 MDM2 (0.40) MAOAMAOBALDH1A1MAPTSMN1; SMN2
SCHEMBL6354674 0.77 MDM2 (0.40) MAOAMAOBALDH1A1MAPTSMN1; SMN2
SCHEMBL6350539 0.76 PRKCB (0.42) ALDH1A1BRD4ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050090498-A1 3-Quinolin-2(1h)-ylideneindolin-2-one derivative YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 2005-04-28 US disclosed
EP-1396490-A1 3-QUINOLINE-2-(1H)-YLIDENEINDOLIN-2-ONE DERIVATIVES YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2004-03-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090498-A1 3-Quinolin-2(1h)-ylideneindolin-2-one derivative KDR, FLT4, FLT1 MAOA 4445/4885MAOB 4555/4885CASP3 846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.